Arrhythmia Risk of Lamotrigine Questioned by Observational Data Two cohort studies didn't find significantly greater risk than other drugs in epilepsy Dec 10, 2024
Empathetic Phone Calls Help Vulnerable Diabetes Patients Lower HbA1c Social support may be key to improving glycemic control, experts say Dec 10, 2024
Rheumatoid Arthritis Boosts Risk for Heart Failure, but Not Every Kind Case-control study reinforces connection between inflammation and HFpEF Dec 09, 2024
Could a Hypertension Drug Protect Against Post-Stroke Epilepsy? Observational study suggests one antihypertensive class might be preventive Dec 09, 2024
Are GLP-1 Drug Holidays a Risk Worth Taking? Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care Dec 08, 2024 video
GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots 20% lower risk of VTE observed in large retrospective study of diabetes patients Dec 08, 2024
Texting to Improve Adherence to CVD Medications; Detecting Maternal Cancers Also in TTHealthWatch: U.S. drug prices under Medicare's price negotiation system Dec 07, 2024 podcast
Women's CVD Risk Calculations Barely Budge When Sex-Specific Variables Are Included Existing models improved only slightly after accounting for certain female risk factors Dec 06, 2024
FDA Panned at Senate Hearing for Failure to Address Diabetes, Obesity Epidemics Agency has failed to hold food manufacturers accountable, said Sen. Bernie Sanders Dec 05, 2024
Asylum Seekers Enter U.S. With Unexpectedly Large Symptom Load Stress, CVD, pain symptoms highly prevalent in those evaluated in New York City Dec 05, 2024
Muscle Loss May Portend Future Dementia But findings should be viewed with caution, expert suggests Dec 05, 2024
Empagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression But the drug didn't appear to lower the risk of incident nonproliferative diabetic retinopathy Dec 05, 2024
Untangling GLP-1 Risks: Are Side Effects Overblown? Experts tackle myths, data bias, and game-changing outcomes of obesity drugs Dec 05, 2024 video
New Study Teases Out Chocolate and Diabetes Connection Eating more dark chocolate was associated with a lower risk of type 2 diabetes Dec 04, 2024
Serious Outcomes of Steatotic Liver Disease Hit Men and Women Differently Liver cancer risk higher among men, while cirrhosis more common in women Dec 04, 2024
Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide Dec 04, 2024
GLP-1s: The Medications Redefining Diabetes and Obesity Treatment Experts tackle access, equity, and the blockbuster drugs reshaping healthcare Dec 04, 2024 video
Daily Chores May Provide Cardiovascular Protection in Women Who Don't Exercise Short bouts of vigorous intermittent lifestyle physical activity tied to lower risk of MACE Dec 03, 2024
Cognitive Performance Falls as Metal Exposure Rises Carrying at least one copy of APOE4 may modify the association Dec 03, 2024
Timelier U.S. Guidelines; Spouse's Personality & CVD; 'Hostile' Cardiologists Out Recent developments of interest in cardiovascular medicine Dec 03, 2024
ASCVD Mortality Linked to Specific Air Pollution Sources Pollution-mortality relationship evidenced at the level of PM2.5 source type Nov 27, 2024
Brain Volume Changes Come 10 Years Sooner for Men With Cardiovascular Risks Men faced neurodegeneration a decade earlier than women Nov 26, 2024
Hunting & Heart Attacks; Cardiologist's Whistleblower Suit; Algorithm Predicts Death Recent developments of interest in cardiovascular medicine Nov 26, 2024
Many Drinkers Cut Back After Starting Obesity Meds, Study Finds In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug Nov 26, 2024
Acoramidis Snags FDA Approval for ATTR Cardiomyopathy Another pricey TTR stabilizer to hit shelves Nov 25, 2024
Medications to Reduce Lipoprotein(a); Genome Models and CVD Risk Also in TTHealthWatch: genetic testing of couples planning pregnancy Nov 23, 2024 podcast
CGM Uptake Very Low for Vulnerable Diabetes Populations But how to achieve equitable use remains "complicated," says expert Nov 22, 2024
Lack of Clinical Benefit of Andexanet Flummoxes FDA Panel Yet advisors were not inclined to take back approval for bleeding reversal agent Nov 21, 2024
GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance Balancing aspiration risk with the consequences of medication discontinuation Nov 20, 2024
Metformin, Lifestyle Changes Fail to Reduce Afib Burden Standard of care prevails in single-center trial Nov 20, 2024
Potassium Binder Cuts Hyperkalemia Risk in HF Patients on Spironolactone More patients taking sodium zirconium cyclosilicate achieved normokalemia vs placebo recipients Nov 20, 2024
Sacubitril/Valsartan Curbs Cardiotoxicity From Chemotherapy Benefit shown in trial of patients flagged for high risk of cardiotoxicity Nov 20, 2024
Fitness Level May Offset Genetic Dementia Risk In middle-age and older adults, high cardiorespiratory fitness was linked with better cognition Nov 19, 2024
Small Benefit, Persistent Toxic Risk With Adjuvant Anthracycline in Breast Cancer Time for "long goodbye" to the "burning red devil," say editorialists Nov 19, 2024
Opioids Tied to Higher Dementia Risk, but Only After a Point Relationships persisted in older adults with chronic pain or who used weak opioids only Nov 19, 2024
More Lp(a)-Reducing Tx; Cardiac Denervation for Afib; LAA Occluders at 5 Years Recent developments of interest in cardiovascular medicine Nov 19, 2024
Nasal Spray Diuretic Shows Potential for Heart Failure in Trial of Healthy Adults Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts Nov 19, 2024
Reused Pacemakers Good as New in Early Safety Data No excess infections when pacemakers were cleaned and repackaged for resource-deprived patients Nov 18, 2024
Novel Anti-Inflammatory Flops for HFpEF, HFmrEF Phase II trial does hold a few signals that might warrant another attempt Nov 18, 2024
